Aminder Mehdi MD in Stockton, California

Home California Stockton

Aminder Mehdi MD has Hematology/oncology as his primary medical specialty. Their primary office is: 2626 N California St in Stockton, California. There is an additional office location, for a total of two, for Aminder Mehdi MD that can be viewed further down.

They're a part of the: Stockton Hematology Oncology Medical Group Inc medical group which has around 8 members. You can call their office at 209-466-2626 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1977 (around 47 years of experience). They are listed as doing telehealth appointments.

Aminder Singh Mehdi MD Office Phone and Directions

Aminder Mehdi MD
Stockton Hematology Oncology Medical Group Inc
2626 N California St
Stockton, California 95204
209-466-2626

Patient Ratings
Please rate your experience with Aminder Mehdi MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 209-466-2626

Enter a starting address:

Healthcare Info for Aminder Mehdi MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Aminder Mehdi MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 47
PAC (PECOS ID)#: 4981612231
NPI #: 1780612507
NPI Created On: 06/29/2006
NPI Last Updated Listed as: 03/09/2020
Primary Taxonomy Code: 174400000X
License Number:
A43019
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Punjabi, Hindi, Chinese.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Nuclear medicine study with ct imaging skull base to mid-thigh
Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673215

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673219

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673217

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673223

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673225

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673229

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673231

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ERLEADA

Associated Drug #2: 59676-600-12

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: BALVERSA

Name Of Drug #3: 59676-030-56

Drug or Biological: Biological

Product Category #4: Oncology

Name of Drug #4: DARZALEX

Associated Drug #4: 57894-502-05

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788673233

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Additional Office Locations

1. Stockton Hematology Oncology Medical Group Inc
801 S Ham Ln
Lodi, CA 95242
Suite S
Group Members: 8

Phone: 209-466-2626

Enter a starting address:

Hematology/oncology Professionals in Stockton

1.
Chun Ng

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

2.
Cong Zhang

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

3.
Hinda Boutrid

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

4.
Nicolaj Andersen MD

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

5.
Ana Rodriguez Fahrni

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

6.
Lisa Law MD

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

Providers in Stockton Hematology Oncology Medical Group Inc

1.Neelesh Bangalore Md

2626 N California St
Stockton Ca 95204-5500
Stockton Hematology Oncology Medical Group Inc
Hematology

2.Neelesh Bangalore Md

801 S Ham Ln
Lodi Ca 95242-7503
Stockton Hematology Oncology Medical Group Inc
Hematology

3.Neelesh Bangalore Md

300 Northgate Dr
Manteca Ca 95336-3139
Stockton Hematology Oncology Medical Group Inc
Hematology

4.Neelesh Bangalore Md

1325 Melrose Ave
Modesto Ca 95350-5581
Stockton Hematology Oncology Medical Group Inc
Hematology

5.Neelesh Bangalore Md

2316 Orchard Pkwy
Tracy Ca 95377-7324
Stockton Hematology Oncology Medical Group Inc
Hematology

6.Mussa Banisadre

2626 N California St
Stockton Ca 95204-5500
Stockton Hematology Oncology Medical Group Inc
Hematology

View all 8 members of Stockton Hematology Oncology Medical Group Inc medical group